Fact CheckerSign in

NCT07865390Not yet recruiting

Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis

Personalizing Inflammatory Arthritis Rheumatology Care: Integrating PROMIS Measures and Patient Preferences to Improve Shared Decision-Making

Source: ClinicalTrials.gov · Last updated 15 Oct 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn whether showing patient-reported symptoms and personal treatment goals to rheumatology clinicians on a dashboard in the electronic health record improves shared decision-making for adults with rheumatoid arthritis or psoriatic arthritis. The main questions it aims to answer are: * Do patients whose clinicians use the dashboard report more shared decision-making during their rheumatology visits than patients who receive usual care? * Do patients in the dashboard group report greater progress toward their personal goals and more confidence in managing their symptoms after 6 months? Researchers will compare the dashboard group to a usual care group to see if the dashboard improves shared decision-making, goal attainment, and self-efficacy. Participants will: * Complete a routine symptom questionnaire before their rheumatology visits, as all clinic patients do * Choose personal treatment goals and rate their progress toward those goals 6 months later * Complete short surveys before and after two rheumatology visits about 6 months apart Participants in the dashboard group will also complete questionnaires in the patient portal about pain, fatigue, physical function, sleep, and morning stiffness before each visit. Their answers and goals will be shown to their clinician on a dashboard to guide the conversation during the visit.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
160 (estimated)
First submitted
3 Oct 2026
Start date
1 Jan 2027
Primary completion date
31 Dec 2027
Lead sponsor
Northwestern University
NCT number
NCT07865390

What you commit to

  • Study type: Interventional
  • Planned participants: 160
  • From 1 Jan 2027 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Unable to provide informed consent
  • Unable to complete study questionnaires in English

Who the study is looking for

  • Age 18 years or older
  • Diagnosis of rheumatoid arthritis or psoriatic arthritis
  • Receiving care at a Northwestern Medicine rheumatology clinic, with an upcoming rheumatology visit
  • Active patient portal (MyChart) account
  • Able to read and complete questionnaires in English
  • Able to provide informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Northwestern Medicine Rheumatology
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.